Lateral Sagittal vs Costoclavicular Brachial Plexus Block in Children
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04215614 |
Recruitment Status :
Completed
First Posted : January 2, 2020
Last Update Posted : April 14, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hand Injuries and Disorders Forearm Injuries | Drug: Lidocaine and Bupivacaine solution Device: Costoclavicular block Device: Lateral Sagittal block | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | The Comparison of Lateral Sagittal vs Costoclavicular Brachial Plexus Block in Children |
Actual Study Start Date : | January 2, 2020 |
Actual Primary Completion Date : | April 3, 2020 |
Actual Study Completion Date : | April 10, 2020 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Group Lateral Sagittal
Ultrasound-Guided lateral sagittal brachial plexus block with 1:1 ratio 2% lidocaine, and 0.5% bupivacaine
|
Drug: Lidocaine and Bupivacaine solution
1:1 ratio 2% lidocaine, and 0.5% bupivacaine Device: Lateral Sagittal block Ultrasound-guided lateral sagittal brachial plexus block |
Active Comparator: Group Costoclavicular
Ultrasound-Guided costoclavicular brachial plexus block with 1:1 ratio 2% lidocaine, and 0.5% bupivacaine
|
Drug: Lidocaine and Bupivacaine solution
1:1 ratio 2% lidocaine, and 0.5% bupivacaine Device: Costoclavicular block Ultrasound-guided costoclavicular brachial plexus block |
- Block performance time [ Time Frame: Twenty minutes before surgery ]The time interval between the contact of the ultrasound probe to skin and end of local anesthetics injection.
- Visual analog pain score [ Time Frame: Postoperative 24 hours ]Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 5 Years to 15 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- American Society of Anesthesiologist's physiologic state I-II patients
- Patients who will undergo hand or forearm surgery
Exclusion Criteria:
- Infection in the area to be injected
- Coagulopathy,
- Previously known neurological damage

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04215614
Turkey | |
Ataturk University | |
Erzurum, Turkey |
Responsible Party: | Ahmet Murat Yayik, Assistant Professor, Ataturk University |
ClinicalTrials.gov Identifier: | NCT04215614 |
Other Study ID Numbers: |
LS vs Costo BPB Pediatric |
First Posted: | January 2, 2020 Key Record Dates |
Last Update Posted: | April 14, 2020 |
Last Verified: | April 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Wounds and Injuries Hand Injuries Forearm Injuries Arm Injuries Lidocaine Bupivacaine Anesthetics, Local Anesthetics Central Nervous System Depressants |
Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents Anti-Arrhythmia Agents Voltage-Gated Sodium Channel Blockers Sodium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action |